Cytokinetics Inc

Visual Financials
Company Name: Cytokinetics Inc
Ticker Symbol: CYTK
CIK Number: 0001061983
WWW Address: http://www.cytokinetics.com
CEO: Robert I. Blum
No. of Employees: 127
Common Issue Type: CS
Business Description:Cytokinetics Inc is a clinical-stage biopharmaceutical company engaged in discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 10.75 Up 1.21 9.7 11.11 9.57 10.58 9.87 550802
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 620.5 57.7 0.00 -1.95 0.00 0.0 0.0 11.33 - 5.75
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close9.88$
PE Ratio - LTM0.0
Market Capitalisation620.5mil
Latest Shares Outstanding57.7mil
Earnings pS (EPS)-1.95$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee242,315$
Effective Tax Rate0.0%
Float45.4mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue1.00%
Research & Devlopment (R&D) as % of Revenue2.80%
Gross Profit Margin0.0%
EBITDA Margin-265.0%
Pre-Tax Profit Margin0.0%
Assets Turnover12.5%
Return on Assets (ROA)-42.0%
Return on Equity (ROE)-156.6%
Return on Capital Invested (ROCI)-83.7%
Current Ratio9.4
Leverage Ratio (Assets/Equity)8.1
Interest Cover-3.9
Total Debt/Equity (Gearing Ratio)1.64
LT Debt/Total Capital61.0%
Working Capital pS3.21$
Cash pS0.00$
Book-Value pS0.06$
Tangible Book-Value pS0.45$
Cash Flow pS-1.80$
Free Cash Flow pS-1.82$
KEY FIGURES (LTM): Price info
Price/Book Ratio172.41
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----4.7510,2841,541,787
4 Weeks11.338.7910.07-1.9512,3509,734,662
13 Weeks11.335.906.2558.1586,15436,927,702
26 Weeks11.335.757.4033.5505,10262,632,688
52 Weeks11.335.758.5515.6422,499105,624,801
YTD11.335.75-44.9539,68058,285,547
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
10.4110.229.337.957.920.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.010.60.03
Income0.0
Dividend0.0
Capital SpendingNA
R&D-7.98NA-2.86
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-54.9-54.989.0
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.040.040.34
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio87.83
Current Ratio9.4
Quick Ratio (Acid Test)9.3
Liquidity Ratio (Cash)10.86
Receivables Turnover18.8
Average Collection Period19
Working Capital/Equity715.2
Working Capital pS3.38
Cash-Flow pS-1.86
Free Cash-Flow pS-1.88
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-0.87
Financial Leverage Ratio (Assets/Equity)1.6
Debt Ratio20.1
Total Debt/Equity (Gearing Ratio)1.64
LT Debt/Equity1.53
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities93.9
Interest Cover-3.9
Interest/Capital Invested83.15
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.75
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-4.06
Enterprise Value (EV)/Free Cash Flow-3.63
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM172.41
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.98
Current Liabilities pS0.55
Tangible Book Value pS - LTM0.45
Book Value pS - LTM0.06
Capital Invested pS1.18
Cash pS - LTM0.00
Cash Flow pS - LTM-1.80
Free Cash Flow pS - LTM-1.82
Earnings pS (EPS)-1.95
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-324.13
Free Cash Flow Margin 5YEAR AVG-231.28
Net Profit Margin-3.4
Net Profit Margin - 5YEAR AVRG.-2.9
Equity Productivity1.21
Return on Equity (ROE)-1.6
Return on Equity (ROE) - 5YEAR AVRG.-0.7
Capital Invested Productivity0.46
Return on Capital Invested (ROCI)-0.4
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.4
Assets Productivity0.10
Return on Assets (ROA)-0.4
Return on Assets (ROA) - 5YEAR AVRG.-0.3
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM-265.0
EBIT Margin - LTM-269.0
Pre-Tax Profit Margin-2.9
Pre-Tax Profit Margin - 5YEAR AVRG.-2.9
Effective Tax Rate-0.0
Effective Tax Rate - 5YEAR AVRG.-0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee242,315
Net Income per Employee
Average Collection Period
Receivables Turnover18.8
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales11.95
Assets/Revenue10.00
Net Working Capital Turnover0.17
Fixed Assets Turnover8.99
Total Assets Turnover0.1
Revenue per $ Cash0.75
Revenue per $ Plant9.83
Revenue per $ Common Equity1.21
Revenue per $ Capital Invested0.46
Selling, General & Adm/tive (SG&A) as % of Revenue99.3
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue283.0
R&D Expense as % of Revenue - 5YEAR AVRG.283.0

  


Your Recent History
NASDAQ
CYTK
Cytokineti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.